FindMyKOL
Clinical trialNCT05004675CompletedPhase 3Interventional

Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients

SponsorLIB Therapeutics LLCEnrollment166Atherosclerotic Ischemic DiseaseHypercholesterolemia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Comparison of LDL-C reductions of lerodalcibep (LIB003) 300 mg to inclisiran (Leqvio®) 284 in patients at very-high risk or high-risk for CVD on stable diet and oral LDL-C-lowering drug therapy
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Chu de Nantes - Hôpital Nord Laennec

    Nantes, Cedex 01, France

  • Hopitaux de Marseille

    Marseille, Cedex 05, France

Germany
  • Universitätsklinikum Heidelberg - Medizinische Klinik

    Heidelberg, Germany

Norway
  • the Lipid Clinic (oslo University Hospital)

    Oslo, Nydalen, Norway

Spain
  • Hospital Universitario Miguel Servet

    Zaragoza, Spain

United Kingdom
  • Oak Tree Surgery and Pensilva Health Centre

    Liskeard, Cornwall, United Kingdom

  • Ashton Medical Group

    Ashton-under-Lyne, Lancashire, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Inclisiran →Lerodalcibep
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Jun 2022
Primary completion
30 May 2024
Completion
15 Oct 2024
Last update posted
23 Oct 2024
Registered enrollment
166
Registry id
NCT05004675
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.